🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cross-sectorial Management Program for People Living with Hand Osteoarthritis: a Randomised Controlled Pilot and Feasibility Study

RecruitingNAAges 18 Years - anyAllParker Research Institute
NCT06794632 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To investigate the research design (pilot-RCT) and feasibility of the HANDY program for people with hand osteoarthritis (version 2.0). In collaboration with two municipalities (Lyngby-Taarbæk and Ballerup), the research design is tested in a pilot-RCT before planning a full-scale RCT study. The entire HANDY program is described in a manual, which has been adjusted to version 2.0 based on a previous feasibility study. The focus of the study will be on procedures related to recruitment and retention, the study's acceptance in practice, and the appropriateness of assessment tools in connection with the occupational therapy group intervention. The feasibility and acceptance of the HANDY program version 2.0 are also examined in this study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * People diagnosed by general practitioner with hand osteoarthritis * Aged \> 18 years * Experiencing decreased ADL ability Exclusion Criteria: * Severe vision loss * Severe hearing loss * Cognitive deficits affecting the ability to engage in peer-learning activities * Unable to participate in two or more group sessions due to other scheduled activities (e.g. holidays/travels). * Acute illness is the primary reason for decreased ADL ability (Will be referred to other services in the municipality).
💊

What it tests

  • HANDY occupational therapy intervention
📍

Where

1 site
The Parker Institute
Copenhagen, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy